Kyntra Bio Operating Margin Growth & History (KYNB)

Kyntra Bio's operating margin was −712.66% for fiscal 2025.

View full Kyntra Bio company overview

Kyntra Bio annual operating margin history

Kyntra Bio annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-12-31−712.66%−204.85 pp
20242024-12-31−507.80%+181.73 pp
20232023-12-31−689.53%−475.63 pp
20222022-12-31−213.90%−91.28 pp
20212021-12-31−122.62%−13.79 pp
20202020-12-31−108.83%−74.02 pp
20192019-12-31−34.81%+5.90 pp
20182018-12-31−40.71%+48.82 pp
20172017-12-31−89.53%−62.21 pp
20162016-12-31−27.32%+15.61 pp
20152015-12-31−42.93%−6.52 pp
20142014-12-31−36.41%−28.63 pp
20132013-12-31−7.78%

Kyntra Bio operating margin trends

Over the last five reported fiscal years, Kyntra Bio's operating margin decreased from −108.83% to −712.66%, a change of −603.83 percentage points. The latest reported quarter, Q1 2026, shows −369.66%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Kyntra Bio filings at SEC.gov ↗